DUBAI, United Arab Emirates – The Middle East Congress for Regenerative Medicine, held on November…
European Wellness Continues Research Funding For Heidelberg University, Germany, on Stem Cell Research and Immunology
On July 9, 2024, we witnessed a meet-up of two medical science pioneers in Stem Cell Research, Prof. Dato’ Sri Dr Mike Chan, the visionary Founder and Chairman of the European Wellness Biomedical Group (EWBG), and Prof. Dr Thomas Skutella, Chief Scientist and Head of Stem Cell Research at the Heidelberg University.
Prof. Dato’ Sri Dr Mike Chan’s contributions to bioregenerative science for 40 years is impeccable.
As a pioneer in stem cell therapy since the mid-80s, his unique individualised therapies have changed many lives.
His ongoing funding and studies at Heidelberg University pushes the boundaries of regenerative medicine.
One of his mentors for many years was Prof. Albert Landsberger from Heidelberg University since the 80s.
The partnership between Baden Research Lab, EWBG, and Heidelberg University exemplifies the value of collaboration in medical research.
This collaboration spanning several years, has produced ground-breaking breakthroughs, particularly in stem cell treatment and regenerative medicine.
These advancements hold enormous promise for curing chronic and degenerative diseases, bringing new hope to humanity.
Prof. Dr Skutella’s considerable research and accomplishments have contributed significantly to the advancement of breakthrough medical solutions.
We were honoured to be warmly welcomed by Prof. Dr Skutella.
His leadership at Heidelberg University has advanced stem cell research to new heights.
During the visit, discussions focused on existing and future financing and research projects.
Together, both parties have been pioneering on all kinds of Stem Cells, from induced pluripotent stem cells, allografts, autografts, xenografts, peptides, to exosomes for decades!
These endeavours seek to provide revolutionary benefits to humanity by developing novel medicines and therapies that greatly improve patient outcomes and quality of life.
This visit is a pivotal moment in our continued relationship, demonstrating our dedication to advancing medical science and innovation.